The effectiveness of nirmatrelvir/ritonavir regimen in hospitalized renal transplant patients with prolonged COVID-19 infection: a multicenter clinical experience

The effectiveness of nirmatrelvir/ritonavir regimen in hospitalized renal transplant patients with prolonged COVID-19 infection: a multicenter clinical experience

Objectives Effectiveness of nirmatrelvir/ritonavir (NR) in kidney transplant recipients (KTRs) infected COVID-19 for more than 5 days has not been evaluated.Methods In this multicenter retrospective study, 85 KTRs with COVID-19 were enrolled, including 50 moderate, 21 severe, and 14 critical patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Huanxi Zhang, Wenrui Wu, Yitao Zheng, Qian Fu, Peisong Chen, Jianyi Li, Zixuan Wu, Jincui Gu, Jun Li, Longshan Liu, Chenglin Wu, Sizhe Long, Bowen Xu, Liuting Ling, Yingxin Fu, Changxi Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Nirmatrelvir/ritonavir
SARS-CoV-2
COVID-19
kidney transplantation
efficacy
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2385724
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2024.2385724

Similar Items